儿童期起病原发性骨质疏松症中PLS3测序鉴定出两个新致病变异
该研究对95例原发性骨脆性儿童进行PLS3基因测序,队列I为31例病因不明的儿童期起病原发性骨质疏松症患者,队列II为64例有多发骨折但其他方面健康的儿童。在队列I的2例患者中鉴定出两个新致病性PLS3变异,而队列II中未发现致病性变异。作者认为儿童期起病原发性骨质疏松症需进行PLS3筛查。
要点
- 在31例病因不明的儿童期起病原发性骨质疏松症患者中,2例检出PLS3新致病变异。
- 64例有多发骨折但其他方面健康的儿童中未检出致病性PLS3变异。
- 两例检出变异患者均有低骨密度、多发外周骨折和椎体骨折,髂嵴活检证实低转换型骨质疏松。
核心结论
- 在儿童期起病原发性骨质疏松症患者中鉴定出两个新致病性PLS3变异,而在骨骼脆性较轻的儿童中未发现致病性变异。
- 作者认为儿童期起病原发性骨质疏松症的男性和女性患者需进行PLS3筛查。
研究设计与样本
- 研究筛查了两个儿童骨脆性队列的PLS3基因变异;队列I为31例病因不明的儿童期起病原发性骨质疏松症患者,队列II为64例有多发骨折但其他方面健康的儿童。
- 对周围血DNA进行Sanger测序,检测PLS3的编码外显子及侧翼内含子区域,并回顾临床和影像学资料。
主要发现
- 队列I中2例患者(已排除其他常见遗传病因)检出两个新致病性PLS3变异。
- 患者1为男性,10岁时发生双侧股骨骨折,18岁时骨密度Z值为-4.1,有多发椎体压缩性骨折,携带新无义变异。
- 患者2为女孩,有多发长骨和椎体骨折,6岁时骨密度Z值为-6.6,携带新发错义变异;全外显子组测序和阵列比较基因组杂交未发现其他遗传病因。
- 两例患者的髂嵴骨活检均证实低转换型骨质疏松。
- 队列II中所有受试者均未检出致病性PLS3变异。
临床怎么用
- 作者认为儿童期起病原发性骨质疏松症的男性和女性患者需进行PLS3筛查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Altogether 95 children with primary bone fragility were screened for variants in PLS3, the gene underlying X-linked osteoporosis. Two children with multiple peripheral and spinal fractures and low BMD had novel disease-causing PLS3 variants. Children with milder phenotypes had no pathogenic variants. PLS3 screening is indicated in childhood-onset primary osteoporosis. INTRODUCTION: The study aimed to determine the role of pathogenic PLS3 variants in children's bone fragility and to elucidate the associated phenotypic features. METHODS: Two cohorts of children with bone fragility were screened for variants in PLS3, the gene underlying X-linked osteoporosis. Cohort I comprised 31 patients with childhood-onset primary osteoporosis of unknown etiology. Cohort II comprised 64 children who had sustained multiple fractures but were otherwise healthy. Clinical and radiological data were reviewed. Peripheral blood DNA was Sanger sequenced for coding exons and flanking intronic regions of PLS3. RESULTS: In two patients of cohort I, where other common genetic causes had been excluded, we identified two novel disease-causing PLS3 variants. Patient 1 was a male with bilateral femoral fractures at 10 years, low BMD (Z-score -4.1; 18 years), and multiple vertebral compression fractures. He had a novel nonsense variant in PLS3. Patient 2 was a girl with multiple long bone and vertebral fractures and low BMD (Z-score -6.6 at 6 years). She had a de novo missense variant in PLS3; whole exome sequencing and array-CGH identified no other genetic causes. Iliac crest bone biopsies confirmed low-turnover osteoporosis in both patients. In cohort II, no pathogenic PLS3 variants were identified in any of the subjects. CONCLUSIONS: Two novel disease-causing variants in PLS3 were identified in a boy and a girl with multiple peripheral and spinal fractures and very low BMD while no pathogenic variants were identified in children with less severe skeletal fragility. PLS3 screening is warranted in male and female patients with childhood-onset primary osteoporosis.
引用
- Kämpe AJ, Costantini A, Mäkitie RE, et al. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. Osteoporos Int. 2017. PMID: 28748388. doi:10.1007/s00198-017-4150-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。